Lymphoma of the Ocular Adnexa and Skin of Eyelid

Primary Site Histology Staging Type
C441, C690, C695-C696 9590-9699, 9702-9738, 9811-9818, 9820-9837 TNM 7 and Summary Stage

If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual

Notes

M-9590-9699,9702-9738, 9811-9818,9820-9837 C441 Skin of Eyelid C690 Conjunctiva C695 Lacrimal Gland C696 Orbit **Note 1:** This schema is based on the UICC chapters *Hodgkin & Non-Hodgkin Lymphomas,* pages 304-310. * UICC does not define Lymphoma Ocular Adnexa. A list of all possible values are provided for T, N and M (no definitions are available) * Assign Clinical and Pathologic Stage Group using the Lymphoma chapter **Note 2:** Laterality must be coded for this site. **Note 3:** In addition to directly assigning Clinical and Pathologic Stage Group, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Hodgkin & Non-Hodgkin Lymphoma of All Sites* chapter on page 284 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=284).

Main Data Items

Name Default Value Used for Staging NAACCR Item Required By Metadata
Clinical T <BLANK> No NAACCR #940 None
Clinical N <BLANK> No NAACCR #950 None
Clinical M <BLANK> No NAACCR #960 None
TNM Clin Stage Group 99 Yes NAACCR #970 None
Pathologic T <BLANK> No NAACCR #880 None
Pathologic N <BLANK> No NAACCR #890 None
Pathologic M <BLANK> No NAACCR #900 None
TNM Path Stage Group 99 Yes NAACCR #910 None
SSF1: Associated with HIV/AIDS 999 No NAACCR #2880 CCCR/Canada
COC
SEER		 None
SSF2: Systemic Symptoms at Diagnosis 999 Yes NAACCR #2890 All None
SSF3: International Prognostic Index (IPI) 988 No NAACCR #2900 CCCR/Canada
COC		 None
SSF4: Follicular Lymphoma Prognostic Index (FLIPI) 988 No NAACCR #2910 None None
SSF5: Ki-67/MIB-1 Labeling Index (LI): Ophthalmic 988 No NAACCR #2920 None None
SSF6: Lactate Dehydrogenase (LDH) 988 No NAACCR #2930 CCCR/Canada
COC		 None
SSF7: Rheumatoid Arthritis 988 No NAACCR #2861 None None
SSF8: Sjogren Syndrome 988 No NAACCR #2862 None None
SSF9: Other Connective Tissue Disease 988 No NAACCR #2863 None None
SSF10: Sicca Syndrome 988 No NAACCR #2864 None None

Additional Data Items

Name Default Value Used for Staging NAACCR Item Required By Metadata
Year of Diagnosis <BLANK> No NAACCR #390 None
Primary Site <BLANK> Yes NAACCR #400 None
Histology <BLANK> Yes NAACCR #522 None

Initial Context

Staging Methods

Expand All | Collapse All

TNM 7 Stage

Inclusion Table

Histology
9590-9699
9702-9738
9811-9818
9820-9837

Start

Additional Context
Pathologic Stage Group = 90
Clinical Stage Group = 90

Next Step

  2. Lymphoma Stage Group Detailed
  3. Clinical Stage Group

Next Step

  2. Lymphoma Path Stage Group Detailed
  3. Pathologic Stage Group

End

Combined Stage

Inclusion Table

Histology
9590-9699
9702-9738
9811-9818
9820-9837

Start

Additional Context
Combined Stage Group = 90

Next Step

  2. Combined Stage Group for Lymphoma
  3. Combined Stage Group

End

Outputs

Name Default Value Description NAACCR Item Metadata
Derived Version 1.2 None None
Derived SEER Clin Stage Group 88 NAACCR #3610
None 		None
Derived SEER Path Stage Group 88 NAACCR #3605
None 		None
Derived SEER Combined Stage Group 88 NAACCR #3614
None 		None
Derived SEER Combined T 88 NAACCR #3616
None 		None
Derived SEER Combined N 88 NAACCR #3618
None 		None
Derived SEER Combined M 88 NAACCR #3620
None 		None
Derived SEER Combined T Source <BLANK> NAACCR #3622
None 		None
Derived SEER Combined N Source <BLANK> NAACCR #3624
None 		None
Derived SEER Combined M Source <BLANK> NAACCR #3626
None 		None